| 1 |
12783488 | Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24. | 2003 Aug 5 |
1 |
| 2 |
11587568 | Production and molecular characterization of clinical phase i anti-melanoma mouse IgG3 monoclonal antibody R24. | 2001 Sep-Oct |
1 |
| 3 |
14533812 | Analysis of a murine anti-ganglioside GD2 monoclonal antibody expressing both IgG2a and IgG3 isotypes: monoclonality, apoptosis triggering, and activation of cellular cytotoxicity on human melanoma cells. | 2001 |
1 |
| 4 |
10941909 | Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors. | 2000 Jul |
1 |
| 5 |
9592190 | 3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study. | 1998 Jun |
1 |
| 6 |
1292783 | Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma. | 1992 Dec |
1 |
| 7 |
1347707 | Absolute requirement of CD11/CD18 adhesion molecules, FcRII and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity. | 1992 Mar 15 |
1 |
| 8 |
1382491 | Immunorecognition of ganglioside epitopes: correlation between affinity and cytotoxicity of ganglioside antibodies. | 1992 |
1 |
| 9 |
2121721 | Monoclonal antibodies to disialogangliosides: characterization of antibody-mediated cytotoxicity against human melanoma and neuroblastoma cells in vitro. | 1990 Jul |
1 |
| 10 |
2653466 | GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. | 1989 May 15 |
1 |
| 11 |
2678480 | Monoclonal antibodies and neuroblastoma. | 1989 Oct |
1 |
| 12 |
3625258 | Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. | 1987 Sep |
1 |
| 13 |
3856277 | Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside. | 1985 Mar |
1 |
| 14 |
3883355 | Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. | 1985 Feb |
1 |